Eleftha 440mg injection

Name: Eleftha 440mg injection
Brand: Vikshar Healthcare Private Limited
Price: 134.35 INR
Availability: InStock

Price 134.35 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Eleftha 440mg injection Specification

Indication
HER2-positive breast cancer

Dosage Form
Injection

Salt Composition
TRASTUZUMAB

Feature
Monoclonal antibody

Ingredients
Trastuzumab 440 mg

Application
Oncology

Physical Color/Texture
White to off-white lyophilized powder

Storage Instructions
Store between 2C to 8C. Do not freeze.

Shelf Life
24 months

Strength
440mg/50ml after reconstitution

MONOCLONAL ANTIBODY TYPE
Humanized

Administered By
Healthcare professional

Sterility
Sterile powder

Packaging Size
VIAL

Marketed By
INTAS PHARMACEUTICALS

Prescription
Required

Indication 2
HER2+ metastatic cancer

Single Use
Yes

Route
IV infusion

Reconstitution
Required

Eleftha 440mg injection Trade Information

Minimum Order Quantity
1 Vial

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

About Eleftha 440mg injection

Eleftha 440mg Injection is a cost-effective, customizable solution for treating HER2-positive breast and metastatic cancer. Marketed by INTAS PHARMACEUTICALS, this resplendent medication contains 440mg of humanized monoclonal antibody Trastuzumab per vial. Its sterile, white to off-white lyophilized powder form ensures impeccable quality upon reconstitution. Designed for IV infusion and single-use, it must be administered by a healthcare professional. Safe and secure packaging upholds sterility, maintaining an enviable standard for oncology therapies. With a shelf life of 24 months, Eleftha embodies a true bargain for patients seeking advanced, reliable cancer treatment.

Versatile Application and Use: Oncology Excellence

Eleftha 440mg Injection is primarily intended for intravenous application under the supervision of a qualified healthcare professional. Its main use is in the treatment of HER2-positive breast cancer as well as HER2+ metastatic cancers. The product's single-use, sterile formulation ensures safety and efficacy for oncology patients. Additionally, this customizable injectable caters to various oncological protocols, making it suitable for broader cancer care needs in diverse clinical settings.

Domestic Delivery & Global Export with Premium Service

Our premium Packing & Dispatch ensure that Eleftha 440mg reaches clients in impeccable condition across the Main Domestic Market-India-and major export destinations worldwide. Flexible payment terms provide added convenience for our customers. We proudly offer this advanced oncology injection to a global market, supported by our standing as a leading exporter, supplier, and trader. Trust in our commitment to delivering top-tier products and seamless service with every offer.

FAQ's of Eleftha 440mg injection:

Q: How should Eleftha 440mg Injection be stored for optimal effectiveness?

A: Always store Eleftha 440mg Injection between 2C and 8C in its original packaging. Do not freeze the vial, as improper storage may affect the medication's sterility and efficacy.

Q: What is the primary benefit of using Eleftha 440mg Injection?

A: Eleftha 440mg Injection delivers an enviable therapeutic effect in HER2-positive breast and metastatic cancer due to its humanized monoclonal antibody, Trastuzumab, offering targeted and advanced cancer care.

Q: When should Eleftha 440mg Injection be used in clinical practice?

A: This injection should be used when prescribed by a healthcare professional for patients diagnosed with HER2-positive breast cancer or HER2+ metastatic cancer. Administration should always follow confirmed indications and medical supervision.

Q: How is Eleftha 440mg Injection administered and reconstituted?

A: A healthcare professional must reconstitute the sterile lyophilized powder with suitable diluent and then deliver it as an intravenous infusion. Strict aseptic techniques and dosage guidelines must be followed.

Q: Where can Eleftha 440mg Injection be purchased or supplied?

A: Eleftha 440mg Injection is available from INTAS PHARMACEUTICALS and distributed by reputable exporters, suppliers, and traders across India and international markets.

Q: What makes Eleftha 440mg Injection a cost-effective and premium choice for oncology?

A: Its combination of bargain pricing, impeccable sterility, proven efficacy, and customizable administration makes Eleftha 440mg Injection a premium choice, providing high-value treatment for oncology professionals and their patients.

Tell us about your requirement